Distribution of genes encoding aminoglycoside modifying enzymes amongst methicillin resistant and methicillin sensitive Staphylococcus aureus isolates from Nigerian hospitals

Staphylococcus aureus has long been recognized as one of the major pathogenic organism of human which is responsible for a variety of infections including life threatening infections such as pneumonia. Aminoglycosides antibiotics play an important role in the therapy of staphylococcal infections despite the increase resistant to these drugs. This study aimed at determining the prevalence of genes encoding aminoglycoside modifying enzymes (AMEs) in clinical isolates of S. aureus from teaching hospitals in Nigeria. In this study, 86 culture collections of S. aureus obtained from 4 teaching hospitals in Nigeria were screened for the presence of genes encoding aminoglycoside resistant genes: (aac(6’)/aph(2”), aph(3’)-IIIa, ant(4’)-Ia) and mecA gene by polymerase chain reaction (PCR). Prior to this, antibiotic susceptibility testing was carried out on all the S. aureus strains against several antibiotics including gentamicin and cefoxitin. The prevalence of mecA gene was 44.2% (38 out of 86 S. aureus). Forty eight (55.8%) of the 86 S. aureus identified as gentamicin resistant phenotypically contained at least one of the 2 gentamicin resistant genes: aac(6’)/aph(2”) or aph(3’)-IIIa while ant(4’)-Ia gene was not detected in any of the isolates. The MIC50 and MIC90 for gentamicin resistant strains were 32 and >256 µg/ml, respectively, while the MIC50 and MIC90 for gentamicin sensitive strains were 1 and 8 µg/ml, respectively. The prevalence of gentamicin resistant genes was 29.3% for aac and 19.0% for aph. No ant gene was detected among the gentamicin resistant strains. SCCmec typing for all the gentamicin resistant methicillin resistant S. aureus strains showed diversity of the isolates with 4 (17.4%) out of the 23 were SCCmec II; 4 (17.4%) out of 23 were SCCmec III and 9 (39.1) out of 23 were SCCmec V while the remaining 8 (34.8%) were non-typeable. Using this scheme gentamicin-methicillin resistant, S. aureus strains were found to be widely distributed in all the four teaching hospitals studied. The study found an association between genes encoding AMEs and mecA on the genome of S. aureus isolates from Nigerian hospitals especially the gentamicin-methicillin resistant S. aureus, hence the need for establishment of effective infection control measures and antibiotic policies that will reduce the emergence of gentamicin methicillin resistant strain. Key words: aac(6’)/aph(2”), aph(3’)-IIIa, ant(4’)-Ia genes, gentamicin methicillin resistant Staphylococcus aureus, Nigeria.

[1]  S. Nielsen,et al.  Molecular Epidemiology and Antimicrobial Susceptibility of Clinical Staphylococcus aureus from Healthcare Institutions in Ghana , 2014, PloS one.

[2]  J. Mustapha,et al.  The non-association of Panton-Valentine leukocidin and mecA genes in the genome of Staphylococcus aureus from hospitals in South Western Nigeria. , 2012, Indian journal of medical microbiology.

[3]  R. Daum,et al.  Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic , 2010, Clinical Microbiology Reviews.

[4]  P. Butcher,et al.  A comparative assessment of ribosomal DNA polymorphisms in methicillin resistant Staphylococcus aureus (MRSA) epidemiology , 2010 .

[5]  Johnson Lin,et al.  Cooccurrence of Predominant Panton-Valentine Leukocidin-Positive Sequence Type (ST) 152 and Multidrug-Resistant ST 241 Staphylococcus aureus Clones in Nigerian Hospitals , 2009, Journal of Clinical Microbiology.

[6]  W. König,et al.  Emergence of a Community-Associated Methicillin-Resistant Staphylococcus aureus Strain with a Unique Resistance Profile in Southwest Nigeria , 2009, Journal of Clinical Microbiology.

[7]  G. Goudarzi,et al.  Prevalence of the genes encoding aminoglycoside-modifying enzymes and methicillin resistance among clinical isolates of Staphylococcus aureus in Tehran, Iran. , 2009, Microbial drug resistance.

[8]  G. Sensabaugh,et al.  Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant Staphylococcus aureus Clone USA300 in Men Who Have Sex with Men , 2008, Annals of Internal Medicine.

[9]  O. Stine,et al.  Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. , 2006, The American journal of medicine.

[10]  T. Louie,et al.  Novel Multiplex PCR Assay for Characterization and Concomitant Subtyping of Staphylococcal Cassette Chromosome mec Types I to V in Methicillin-Resistant Staphylococcus aureus , 2005, Journal of Clinical Microbiology.

[11]  Jin-Hong Yoo,et al.  Copyright � The Korean Academy of Medical Sciences Multiplex PCR for the Detection of Genes Encoding Aminoglycoside Modifying Enzymes and Methicillin Resistance among Staphylococcus Species , 2003 .

[12]  C. Boye,et al.  Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  F. Vandenesch,et al.  Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Robert S. Daum,et al.  Novel Type of Staphylococcal Cassette Chromosome mec Identified in Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains , 2002, Antimicrobial Agents and Chemotherapy.

[15]  J. Verhoef,et al.  The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals. , 1999, The Journal of antimicrobial chemotherapy.

[16]  P. Rather,et al.  Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. , 1993, Microbiological reviews.

[17]  S. Shulman,et al.  Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis. , 1986, The Journal of infectious diseases.

[18]  G. Eliopoulos,et al.  Antibiotic synergism and antimicrobial combinations in clinical infections. , 1982, Reviews of infectious diseases.

[19]  D. Rubin,et al.  Methicillin resistant staphylococci. , 1971, JAMA.

[20]  J. Stockman Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant Staphylococcus aureus Clone USA300 in Men Who Have Sex with Men , 2009 .